fda warning bpc-157 2023 2024 FDA's Overreach on Compounded Peptides The U.S. Food and Drug

The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York NBC News The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger looking skin, Instagram As interest in weight loss medications and peptide therapies continues to grow, doctors are warning consumers about the risks associated with unregulated peptides that are increasingly being marketed online for weight loss The hype around a new class of injectable drugs is in overdrive, but they have yet to be properly tested. Read the full story from Kishor Napier Raman at the link in bio., Photo: Oscar Colman Is the @fda ending its war on #peptides ?? @seckennedy A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring!

SKU: 41756155045 · From meijijudolehavre.com